srinviastantravahiMD

PubMed

• CML and the WHO: Why?
  Ellin Berman, Neil P Shah, Michael Deninger, Jessica K Altman, Maria Amaya, Kebede Begna, Ravi Bhatia, Onyee Chan, Robert Collins, Peter Curtin, Daniel J DeAngelo, Mic...> ;Journal of Clinical Oncology. 2024 Mar 20
• Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
  Neil P Shah, Ravi Bhatia, Jessica K Altman, Maria Amaya, Kebede H Begna, Ellin Berman, Onyee Chan, Joan Clements, Robert H Collins, Peter T Curtin, Daniel J DeAngelo, ...> ;Journal of the National Comprehensive Cancer Network. 2024 Feb 1
• 2 citations
  Impact of academic medical center access on outcomes in multiple myeloma.
  Victoria A Vardell, Daniel A Ermann, Srinivas K Tantravahi, Benjamin Haaland, Brian McClune, Amandeep Godara, Ghulam Rehman Mohyuddin, Douglas W Sborov> ;American Journal of Hematology. 2023 Jan 1
• Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemia.
  Srinivas K Tantravahi, Bryan D Huber, Jennie Vagher, Luke Maese, Anthony D Pomicter, Najla Al-Sweel, Julie D Asch, Reha M Toydemir, Bo Hong, Charles Parker> ;British Journal of Haematology. 2022 Sep 1
• 15 citations
  Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study.
  Naveen Pemmaraju, Jacqueline S Garcia, Jalaja Potluri, Jason G Harb, Yan Sun, Paul Jung, Qin Q Qin, Srinivas K Tantravahi, Srdan Verstovsek, Claire Harrison> ;The Lancet. Haematology. 2022 Jun 1
• 45 citations
  Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy.
  Claire N Harrison, Jacqueline S Garcia, Tim C P Somervaille, James M Foran, Srdan Verstovsek, Catriona Jamieson, Ruben Mesa, Ellen K Ritchie, Srinivas K Tantravahi, Pa...> ;Journal of Clinical Oncology. 2022 May 20
• 21 citations
  Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
  Ronald S. Go, Eric D. Jacobsen, Robert A. Baiocchi, Ilia Buhtoiarov, Erin Butler, Patrick K Campbell, Don W. Coulter, Eli L. Diamond, Aron Flagg, Aaron M. Goodman, Gau...> ;Journal of the National Comprehensive Cancer Network. 2021 Nov 1
• 6 citations
  A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm.
  Peng Li, Shobi Venkatachalam, Daniela Ospina Cardona, Lorena Wilson, Tibor Kovacsovics, Karen A. Moser, Rodney R. Miles, David B. Beck, Tracy I. George, Srinivas K. Ta...> ;Blood Advances. 2021 Oct 14
• 29 citations
  Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult AML patients.
  Fei Yang, Nicola Long, Tauangtham Anekpuritanang, Daniel Bottomly, Jonathan C. Savage, Tiffany L. Lee, Jose M Solis-Ruiz, Uma Borate, Beth Wilmot, Cristina E. Tognon, ...> ;Blood. 2021 Sep 5
• 6 citations
  Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms.
  Ami B. Patel, Anthony D. Pomicter, Dongqing Yan, Anna M. Eiring, Orlando Antelope, Jonathan A. Schumacher, Todd W. Kelley, Srinivas K. Tantravahi, Tibor Kovacsovics, P...> ;Leukemia. 2020 May 14
• 30 citations
  In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab
  Djordje Atanackovic, Sara Yousef, Christa Shorter, Srinivas K. Tantravahi, Mary Steinbach, Fiorella Iglesias, Douglas W. Sborov, Sabarinath Venniyil Radhakrishnan, Mar...> ;Leukemia. 2020 Jan 1
• 23 citations
  The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations.
  Anca Franzini, Anthony D. Pomicter, Dongqing Yan, Jamshid S. Khorashad, Srinivas K. Tantravahi, Hein Than, Jonathan M. Ahmann, Thomas O'Hare, Michael W. Deininger> ;Blood Advances. 2019 Oct 22
• 6 citations
  Cost-effectiveness of antifungal prophylaxis, preemptive therapy, or empiric treatment following allogeneic hematopoietic stem cell transplant.
  Brandon S. Walker, Robert L. Schmidt, Srinivas K. Tantravahi, Kibum Kim, Kimberly E. Hanson> ;Transplant Infectious Disease. 2019 Oct 1
• 25 citations
  Nuclear–cytoplasmic transport is a therapeutic target in myelofibrosis
  Dongqing Yan, Anthony D. Pomicter, Srinivas K. Tantravahi, Clinton C. Mason, Anna V. Senina, Jonathan M. Ahmann, Qiang Wang, Hein Than, Ami B. Patel, William L. Heaton...> ;Clinical Cancer Research. 2019 Apr 1
• Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular en...
  Erin B. Bailey, Joseph Merriman, Benjamin L. Maughan, Austin Poole, Srinivas K. Tantravahi, Archana M. Agarwal, Julia A. Batten, Shiven B. Patel, Sumanta K. Pal, David...> ;Journal of Oncology Pharmacy Practice. 2018 Apr 1
• 5 citations
  Minimal Residual Disease Eradication in CML: Does It Really Matter?
  Srinivas K. Tantravahi, Raga S. Guthula, Thomas O'Hare, Michael W. Deininger> ;Current Hematologic Malignancy Reports. 2017 Aug 29
• 2 citations
  Rapid onset of hemophagocytic lymphohistiocytosis in a patient with refractory chronic lymphocytic leukemia treated with ibrutinib
  Austin Poole, Frederic Clayton, Srinivas K. Tantravahi> ;Leukemia & Lymphoma. 2017 May 1
• 3 citations
  Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2.
  David Gill, David D. Stenehjem, Kinjal Parikh, Joseph Merriman, Arun Sendilnathan, Archana M. Agarwal, Andrew W. Hahn, Sumati Gupta, Srinivas K. Tantravahi, Wolfram E....> ;Ecancermedicalscience. 2016 Sep 29
• 13 citations
  Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.
  Straubhar, A. M., David D. Stenehjem, Michael Toole, Joseph Merriman, Kinjal Parikh, Stephanie Daignault, Sarah Scarlett, Peg Esper, Katherine A. Skinner, Aaron M. Uda...> ;Cancer Immunology, Immunotherapy. 2016 Jun 8
• 10 citations
  Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic Therapies.
  Shiven B. Patel, David D. Stenehjem, David Gill, Srinivas K. Tantravahi, Archana M. Agarwal, Joanne Hsu, Winston Vuong, Sumanta K. Pal, Neeraj Agarwal> ;Clinical Genitourinary Cancer. 2016 Apr 1
• 18 citations
  A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia
  Srinivas K. Tantravahi, Philippe Szankasi, Jamshid S. Khorashad, Kim Hien T. Dao, Tibor Kovacsovics, Todd W. Kelley, Michael W. Deininger> ;Leukemia & Lymphoma. 2016 Feb 8
• 13 citations
  Correlation of degree of hypothyroidism with survival outcomes in patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor t...
  Erin B. Bailey, Srinivas K. Tantravahi, Austin Poole, Archana M. Agarwal, Alli M. Straubhar, Julia A. Batten, Shiven B. Patel, Chesley E. Wells, David D. Stenehjem, Ne...> ;Clinical Genitourinary Cancer. 2015 Jun 1
• 20 citations
  Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.
  Anna M Eiring, Brent D G Page, Ira L Kraft, Clinton C Mason, Nadeem A Vellore, Diana Resetca, Matthew S Zabriskie, Tian Y Zhang, Jamshid S Khorashad, Alexander J Engar...> ;Leukemia. 2015 Mar 1
• 5 citations
  Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma
  Srinivas K. Tantravahi, Dan Albertson, Archana M. Agarwal, Sowmya Ravulapati, Austin Poole, Shiven B. Patel, Jamil S. Hawatmeh, Alli M. Straubhar, Ting Liu, David D. S...> ;Journal of Oncology. 2015 Jan 20
• 1 citations
  Systemic mastocytosis in a patient with Cowden syndrome.
  Srinivas K. Tantravahi, Jonathan A. Schumacher, Randall W. Burt, Todd W. Kelley, Michael W. Deininger> ;American Journal of Hematology. 2014 Dec 1
• Join now to see all